Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(25%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_4
2
25%
Ph not_applicable
1
13%
Ph phase_3
3
38%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Recruiting2
Terminated1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 33 (37.5%)
Phase 42 (25.0%)
N/A1 (12.5%)

Trials by Status

terminated113%
completed338%
recruiting225%
unknown113%
withdrawn113%

Recent Activity

2 active trials
Showing 5 of 8
recruitingphase_3

Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit

NCT05696093
recruitingphase_3

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus

NCT05117398
completedphase_4

Individualized Antibiotic Therapy in Children With Acute Uncomplicated Febrile Urinary Tract Infection

NCT05301023
unknownphase_2

Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections

NCT04859621
completednot_applicable

The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics

NCT03657836
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05696093Phase 3

Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit

Recruiting
NCT05117398Phase 3

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus

Recruiting
NCT05301023Phase 4

Individualized Antibiotic Therapy in Children With Acute Uncomplicated Febrile Urinary Tract Infection

Completed
NCT04859621Phase 2

Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections

Unknown
NCT03657836Not Applicable

The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics

Completed
NCT02148601Phase 2

Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection

Completed
NCT03592082Phase 4

Use of Bismuth Subsalicylate in Clostridium Difficile Colitis

Withdrawn
NCT00307099Phase 3

Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8